Skip to content
Close
Oct 22, 2026
Market cap
$2.05M
1.66M shares
Filings
510
$0.00
Q3 2023
—
$452.00K
Q2 2026N/M FY25 yoy
$227.00K
Q2 2026N/M FY25 yoy
—
—
—
$0.27
Q2 2026N/M FY25 yoy
$1.54M
Q2 2026−85.5% FY25 yoy
$2.05M
—
—
—
—
—

FY2025 figures · derived

Price

$1.23+78.26%+$0.54past year
Oct 22, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$300.00KFY 2021
$300.00K0FY 2021
PeriodEndedValueKindSource trail
FY 20212021-12-31$300,000reported

Biological products, except diagnostic substances

BioAtla, Inc. is the 162nd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

BioAtla, Inc. · CIK 1826892 · Engraved from SEC EDGAR